Literature DB >> 9811335

Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure.

A H Fischer1, J A Bond, P Taysavang, O E Battles, D Wynford-Thomas.   

Abstract

Current evidence suggests the papillary thyroid carcinoma oncogene (RET/PTC) generates papillary thyroid carcinomas in one genetic step. We tested a resulting prediction that RET/PTC expression in thyroid epithelium should be sufficient to cause the changes in nuclear morphology diagnostic of this tumor. Primary cultures of human thyroid epithelial cells were infected with a RET/PTC retroviral construct. Morphological scoring by two independent cytopathologists shows RET/PTC expression by immunohistochemistry to be highly associated (p << 0.0001) with an irregular nuclear contour and a euchromatic appearance compared with non-expressing cells in the same cultures. The altered nuclear morphology is not due to gene transfer or transformation per se as primary thyroid cell cultures infected with a retroviral H-RAS construct differ from RET/PTC-infected cells by showing round nuclear envelopes and coarser chromatin, as determined by the independent scoring of two cytopathologists (p << 0.0001). In addition, RET/ PTC-transfected cells appear to disperse, whereas RAS-transfected cells grow as discrete colonies. The results provide additional support for the hypothesis that RET/PTC is sufficient to cause papillary thyroid carcinomas. A signaling pathway downstream of RET/ PTC leads to restructuring of the nuclear envelope and chromatin, and the signal does not depend entirely, if at all, on a RAS pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811335      PMCID: PMC1853418          DOI: 10.1016/S0002-9440(10)65731-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

1.  A t(10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma.

Authors:  G Sozzi; I Bongarzone; M Miozzo; M G Borrello; M G Blutti; S Pilotti; G Della Porta; M A Pierotti
Journal:  Genes Chromosomes Cancer       Date:  1994-04       Impact factor: 5.006

Review 2.  Rearrangements of TRK proto-oncogene in papillary thyroid carcinomas.

Authors:  M A Pierotti; I Bongarzone; M G Borrello; C Mariani; C Miranda; G Sozzi; A Greco
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

3.  Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident.

Authors:  T Ito; T Seyama; K S Iwamoto; T Mizuno; N D Tronko; I V Komissarenko; E D Cherstovoy; Y Satow; N Takeichi; K Dohi
Journal:  Lancet       Date:  1994-07-23       Impact factor: 79.321

4.  Cytogenetic findings in 31 papillary thyroid carcinomas.

Authors:  L Roque; A L Clode; P Gomes; J Rosa-Santos; J Soares; S Castedo
Journal:  Genes Chromosomes Cancer       Date:  1995-07       Impact factor: 5.006

5.  Development of a single-step duplex RT-PCR detecting different forms of ret activation, and identification of the third form of in vivo ret activation in human papillary thyroid carcinoma.

Authors:  S M Jhiang; P A Smanik; E L Mazzaferri
Journal:  Cancer Lett       Date:  1994-04-01       Impact factor: 8.679

6.  Tyrosines outside the kinase core and dimerization are required for the mitogenic activity of RET/ptc2.

Authors:  K Durick; V J Yao; M G Borrello; I Bongarzone; M A Pierotti; S S Taylor
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

Review 7.  Molecular defects in thyroid carcinomas: role of the RET oncogene in thyroid neoplastic transformation.

Authors:  M Santoro; M Grieco; R M Melillo; A Fusco; G Vecchio
Journal:  Eur J Endocrinol       Date:  1995-11       Impact factor: 6.664

Review 8.  The ret/PTC oncogene in papillary thyroid carcinoma.

Authors:  S M Jhiang; E L Mazzaferri
Journal:  J Lab Clin Med       Date:  1994-03

9.  RET/PTC oncogene activation is an early event in thyroid carcinogenesis.

Authors:  G Viglietto; G Chiappetta; F J Martinez-Tello; F H Fukunaga; G Tallini; D Rigopoulou; R Visconti; A Mastro; M Santoro; A Fusco
Journal:  Oncogene       Date:  1995-09-21       Impact factor: 9.867

10.  Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cells.

Authors:  D Califano; C Monaco; G de Vita; A D'Alessio; N A Dathan; R Possenti; G Vecchio; A Fusco; M Santoro; V de Franciscis
Journal:  Oncogene       Date:  1995-07-06       Impact factor: 9.867

View more
  21 in total

1.  Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

Authors:  Jennifer L Hunt; Zubair W Baloch; Leon Barnes; Patricia A Swalsky; Cindy L Trusky; E Sesatomi; Sydney Finkelstein; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Confocal microscope analysis and tridimensional reconstruction of papillary thyroid carcinoma nuclei.

Authors:  Mauro Papotti; Andrea D Manazza; Roberto Chiarle; Gianni Bussolati
Journal:  Virchows Arch       Date:  2004-01-31       Impact factor: 4.064

3.  Nuclear envelope irregularity is induced by RET/PTC during interphase.

Authors:  Andrew H Fischer; Panya Taysavang; Sissy M Jhiang
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 4.  Causes and consequences of nuclear envelope alterations in tumour progression.

Authors:  Emily S Bell; Jan Lammerding
Journal:  Eur J Cell Biol       Date:  2016-06-25       Impact factor: 4.492

5.  Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene.

Authors:  Maria Grazia Borrello; Luisella Alberti; Andrew Fischer; Debora Degl'innocenti; Cristina Ferrario; Manuela Gariboldi; Federica Marchesi; Paola Allavena; Angela Greco; Paola Collini; Silvana Pilotti; Giuliana Cassinelli; Paola Bressan; Laura Fugazzola; Alberto Mantovani; Marco A Pierotti
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

6.  c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus.

Authors:  Sherif F Louis; Bart J Vermolen; Yuval Garini; Ian T Young; Amanda Guffei; Zelda Lichtensztejn; Fabien Kuttler; Tony C Y Chuang; Sharareh Moshir; Virginie Mougey; Alice Y C Chuang; Paul Donald Kerr; Thierry Fest; Petra Boukamp; Sabine Mai
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-27       Impact factor: 11.205

Review 7.  Understanding the genotype of follicular thyroid tumors.

Authors:  Jennifer Hunt
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

Review 8.  Values of molecular markers in the differential diagnosis of thyroid abnormalities.

Authors:  T M P B Tennakoon; M Rushdhi; A D C U Ranasinghe; R S Dassanayake
Journal:  J Cancer Res Clin Oncol       Date:  2016-12-22       Impact factor: 4.553

9.  RET/PTC and CK19 expression in papillary thyroid carcinoma and its clinicopathologic correlation.

Authors:  Eunah Shin; Woung Youn Chung; Woo Ick Yang; Cheong Soo Park; Soon Won Hong
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

10.  RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

Authors:  Giuliana Cassinelli; Enrica Favini; Debora Degl'Innocenti; Alessandro Salvi; Giuseppina De Petro; Marco A Pierotti; Franco Zunino; Maria Grazia Borrello; Cinzia Lanzi
Journal:  Neoplasia       Date:  2009-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.